Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
To receive this treatment, kindly schedule an appointment for in-clinic treatment or visit us directly as a walk-in patient
BPC-157 was placed in Category 2 ("may present significant safety risks") in 2023, removed from that category in April 2026, and is now set for a Pharmacy Compounding Advisory Committee review in late July 2026, while CJC-1295 and Ipamorelin were placed in Category 2 back in October 2023
For a person taking the standard dose, a years supply would cost $6,000
PubMed 27
Gastrointestinal protection: BPC-157 was originally discovered in gastric juice and has been shown to protect the gastrointestinal tract from damage caused by various agents, such as NSAIDs (nonsteroidal anti-inflammatory drugs), alcohol, and stress
US$ 20.90
US$ 27.20
US$ 25.64
US$ 23.40
US$ 27.17
US$ 25.09
